PF-05180999

DRUG3 trials

Sponsors

Pfizer

Conditions

HealthyMigraineSchizophrenia

Phase 1

A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults

CompletedNCT01429740

PfizerSchizophrenia

Start: 2011-08-31End: 2011-12-31Updated: 2012-04-12

A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999

CompletedNCT01530529

Start: 2012-01-31End: 2012-04-30Updated: 2012-05-01

A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults

TerminatedNCT01981499

Start: 2014-01-31End: 2014-04-30Updated: 2014-05-08